283 related articles for article (PubMed ID: 27894718)
1. Chlamydia suis and Chlamydia trachomatis induce multifunctional CD4 T cells in pigs.
Käser T; Pasternak JA; Delgado-Ortega M; Hamonic G; Lai K; Erickson J; Walker S; Dillon JR; Gerdts V; Meurens F
Vaccine; 2017 Jan; 35(1):91-100. PubMed ID: 27894718
[TBL] [Abstract][Full Text] [Related]
2. Antibody-neutralizing activity against all urogenital Chlamydia trachomatis serovars in Chlamydia suis-infected pigs.
Donati M; Di Francesco A; Delucca F; Di Paolo M; Battilani M; Balboni A; Baldelli R; Cevenini R
FEMS Immunol Med Microbiol; 2011 Feb; 61(1):125-8. PubMed ID: 21214636
[TBL] [Abstract][Full Text] [Related]
3. Porcine retinal cell line VIDO R1 and Chlamydia suis to modelize ocular chlamydiosis.
Käser T; Cnudde T; Hamonic G; Rieder M; Pasternak JA; Lai K; Tikoo SK; Wilson HL; Meurens F
Vet Immunol Immunopathol; 2015 Aug; 166(3-4):95-107. PubMed ID: 26103808
[TBL] [Abstract][Full Text] [Related]
4.
De Clercq E; Van Gils M; Schautteet K; Devriendt B; Kiekens C; Chiers K; Van Den Broeck W; Cox E; Dean D; Vanrompay D
Front Immunol; 2020; 11():555305. PubMed ID: 33193323
[TBL] [Abstract][Full Text] [Related]
5. The Predominant CD4
Jordan SJ; Gupta K; Ogendi BMO; Bakshi RK; Kapil R; Press CG; Sabbaj S; Lee JY; Geisler WM
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28100498
[No Abstract] [Full Text] [Related]
6. Development of a Chlamydia suis-specific antibody enzyme-linked immunosorbent assay based on the use of a B-cell epitope of the polymorphic membrane protein C.
De Puysseleyr K; Kieckens E; De Puysseleyr L; Van den Wyngaert H; Ahmed B; Van Lent S; Creasy HH; Myers GSA; Vanrompay D
Transbound Emerg Dis; 2018 Apr; 65(2):e457-e469. PubMed ID: 29314736
[TBL] [Abstract][Full Text] [Related]
7. Characterization of protective immune responses promoted by human antigen targets in a urogenital Chlamydia trachomatis mouse model.
Olsen AW; Andersen P; Follmann F
Vaccine; 2014 Feb; 32(6):685-92. PubMed ID: 24365515
[TBL] [Abstract][Full Text] [Related]
8. Co-Occurrence of
Kieckens E; Van den Broeck L; Van Gils M; Morré S; Vanrompay D
Vector Borne Zoonotic Dis; 2018 Dec; 18(12):677-682. PubMed ID: 30251925
[No Abstract] [Full Text] [Related]
9. Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile.
Picard MD; Bodmer JL; Gierahn TM; Lee A; Price J; Cohane K; Clemens V; DeVault VL; Gurok G; Kohberger R; Higgins DE; Siber GR; Flechtner JB; Geisler WM
Clin Vaccine Immunol; 2015 Nov; 22(11):1206-18. PubMed ID: 26446421
[TBL] [Abstract][Full Text] [Related]
10. Intravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage.
Vicetti Miguel RD; Quispe Calla NE; Pavelko SD; Cherpes TL
PLoS One; 2016; 11(9):e0162445. PubMed ID: 27606424
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity against Chlamydia trachomatis can engage both CD4+ and CD8+ T cells and bridge the respiratory and genital mucosae.
Nogueira CV; Zhang X; Giovannone N; Sennott EL; Starnbach MN
J Immunol; 2015 Mar; 194(5):2319-29. PubMed ID: 25637024
[TBL] [Abstract][Full Text] [Related]
12. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
Marks E; Verolin M; Stensson A; Lycke N
Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
[TBL] [Abstract][Full Text] [Related]
13. The immune response against Chlamydia suis genital tract infection partially protects against re-infection.
De Clercq E; Devriendt B; Yin L; Chiers K; Cox E; Vanrompay D
Vet Res; 2014 Sep; 45(1):95. PubMed ID: 25252649
[TBL] [Abstract][Full Text] [Related]
14. A mouse model for Chlamydia suis genital infection.
Donati M; Di Paolo M; Favaroni A; Aldini R; Di Francesco A; Ostanello F; Biondi R; Cremonini E; Ginocchietti L; Cevenini R
Pathog Dis; 2015 Feb; 73(1):1-3. PubMed ID: 25854004
[TBL] [Abstract][Full Text] [Related]
15. Gamma Interferon Is Required for
Helble JD; Gonzalez RJ; von Andrian UH; Starnbach MN
mBio; 2020 Mar; 11(2):. PubMed ID: 32184237
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an ompA-based phage-mediated DNA vaccine against Chlamydia abortus in piglets.
Ou C; Tian D; Ling Y; Pan Q; He Q; Eko FO; He C
Int Immunopharmacol; 2013 Aug; 16(4):505-10. PubMed ID: 23669337
[TBL] [Abstract][Full Text] [Related]
17. Chlamydia trachomatis: Protective Adaptive Responses and Prospects for a Vaccine.
Poston TB; Darville T
Curr Top Microbiol Immunol; 2018; 412():217-237. PubMed ID: 27033698
[TBL] [Abstract][Full Text] [Related]
18. A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigs.
Bøje S; Olsen AW; Erneholm K; Agerholm JS; Jungersen G; Andersen P; Follmann F
Immunol Cell Biol; 2016 Feb; 94(2):185-95. PubMed ID: 26268662
[TBL] [Abstract][Full Text] [Related]
19. B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis.
Johansson M; Ward M; Lycke N
Immunology; 1997 Dec; 92(4):422-8. PubMed ID: 9497482
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia suis is associated with intestinal NF-κB activation in experimentally infected gnotobiotic piglets.
Aumayer H; Leonard CA; Pesch T; Prähauser B; Wunderlin S; Guscetti F; Borel N
Pathog Dis; 2020 Aug; 78(6):. PubMed ID: 32804203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
